ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation

Go back to ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation
(NASDAQ: IBRX) Delayed: 7.10 -0.1 (1.39%)
Previous Close $7.20    52 Week High
Open $7.24    52 Week Low
Day High $7.32    P/E N/A 
Day Low $7.04    EPS
Volume 8,801,324